解决儿童功能性便秘问题:呼吁全面,协同管理.
1Department of Pediatrics, The First Affiliated Hospital of Yangtze University, Jingzhou 434000, Hubei Province, China.
World journal of gastroenterology
|February 24, 2025
概括
儿童的功能性便秘 (FC) 是常见的和复杂的. 早期诊断和管理,包括所培训和聚乙烯糖醇,是关键的,新兴的疗法和生活方式的改变支持治疗.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 儿童的消化系统健康
背景情况:
- 功能性便秘 (FC) 是一种流行的儿科胃肠道疾病,根据罗马IV标准,全球影响14.4%.
- 了解FC的多因素病原和诊断挑战对于有效的干预至关重要.
研究的目的:
- 探索儿科功能性便秘的发病和诊断复杂性.
- 审查目前和新兴的儿童FC的管理策略.
主要方法:
- 文献综述和关于FC病原和治疗的当前研究的综合.
- 对儿科FC的诊断标准和管理指南的分析.
主要成果:
- 有效的FC管理包括以儿童为中心的所培训和像聚乙烯糖醇这样的透性药.
- 新兴疗法 (益生菌,5-HT4激动剂等) 表明有前途,但需要更多的研究.
- 改变生活方式和物理治疗是药理治疗的重要补充.
结论:
- 对于难以治愈的儿科FC病例,一个多学科的方法是必不可少的.
- 包括研究和教育在内的综合护理改善了FC儿童及其家人的生活质量.
更多相关视频
相关概念视频
Drugs for Treatment of Constipation-Predominant IBS
125
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
125
Irritable Bowel Syndrome III: Medical and Nursing Management
139
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
139
Inflammatory Bowel Disease V: Surgical Management
87
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
87
Drugs Affecting GI Tract Motility: Other Laxatives
159
Laxatives are primarily used to alleviate constipation, a common gastrointestinal disorder characterized by infrequent bowel movements and difficulty passing stools. They work by various mechanisms to increase the volume or frequency of bowel movements. The primary modes of action of laxatives include increasing stool bulk, softening the stool, stimulating intestinal motility, and osmotically drawing water into the intestines.
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
Osmotic or saline laxatives, like magnesium hydroxide or milk of...
159
Drugs for Treatment of Diarrhea-Predominant IBS
140
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
140
Drugs Affecting GI Tract Motility: Bulk-Forming and Stimulant Laxatives
184
Laxatives enhance bowel movements and alleviate constipation. They augment the stool's bulk, stimulate intestinal muscle contractions, draw water into the intestines, or soften the stool. There are five key types of laxatives: bulk laxatives, stimulant laxatives, osmotic laxatives, stool softeners, and lubricant laxatives.
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
Bulk-forming laxatives, such as psyllium, methylcellulose, and polycarbophil, absorb water in the intestine, increasing stool bulk and promoting bowel movement. This...
184


